Clinical Trials Logo

Normal Eyes clinical trials

View clinical trials related to Normal Eyes.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05792046 Completed - Normal Eyes Clinical Trials

IMOvifa Perimeter Reference Database

Start date: March 1, 2023
Phase:
Study type: Observational

This study will collect data to establish a reference database for the IMOvifa perimeter.

NCT ID: NCT04604002 Completed - Retinal Vascular Clinical Trials

Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types

OCTA
Start date: October 15, 2020
Phase:
Study type: Observational

Assessment of image quality and clinical relevance of OCT Angiography at different speed/ART combinations

NCT ID: NCT04068818 Completed - Eye Abnormalities Clinical Trials

The Heidelberg Engineering ANTERION Imaging Agreement Study

Start date: August 22, 2019
Phase:
Study type: Observational

This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess image quality of acquired biometry images of the eye

NCT ID: NCT03279939 Completed - Retinal Vascular Clinical Trials

Evaluation of Heidelberg Engineering SPECTRALIS With OCT Angiography Module

Start date: August 23, 2017
Phase: N/A
Study type: Interventional

Assessment of image quality and clinical relevance of OCT Angiography via comparison to FA/ICGA.

NCT ID: NCT02856139 Completed - Normal Eyes Clinical Trials

Appearance of Far Peripheral Retina in Normal Eyes by Ultra-widefield Fluorescein Angiography

Start date: November 2014
Phase: N/A
Study type: Observational

PURPOSE: To characterize the appearance of the far peripheral retina of normal eyes using ultra-widefield fluorescein angiography (UWFA). DESIGN: Prospective observational case series. METHODS: This study enrolled normal eyes with best corrected visual acuity ≥ 20/20, refractive error < 3.00D, and without visible retinal pathologic changes under a slit lamp-based condensing lens. The far peripheral retina was detected by UWFA. Ciliary body thickness (CBT) at 3 mm (CBT1) and 2 mm (CBT2) posterior to the scleral spur was measured by ultrasound biomicroscopy.

NCT ID: NCT02045823 Completed - Normal Eyes Clinical Trials

OCT Agreement and Precision Study

Start date: January 2014
Phase:
Study type: Observational

To demonstrate clinical substantial equivalence of 3D OCT-1 Maestro as comparable to the commercially available iVue and NW-300. Also, to demonstrate clinical substantial equivalence of 3D OCT-2000 Maestro as comparable to the commercially available NW-300.